Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 910

1.

GGC repeat expansion of NOTCH2NLC in adult patients with leukoencephalopathy.

Okubo M, Doi H, Fukai R, Fujita A, Mitsuhashi S, Hashiguchi S, Kishida H, Ueda N, Morihara K, Ogasawara A, Kawamoto Y, Takahashi T, Takahashi K, Nakamura H, Kunii M, Tada M, Katsumoto A, Fukuda H, Mizuguchi T, Miyatake S, Miyake N, Suzuki J, Ito Y, Sone J, Sobue G, Takeuchi H, Matsumoto N, Tanaka F.

Ann Neurol. 2019 Aug 21. doi: 10.1002/ana.25586. [Epub ahead of print]

PMID:
31433517
2.

Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH Study.

Hartung HP, Mallick R, Bril V, Lewis RA, Sobue G, Lawo JP, Mielke O, Durn BL, Cornblath DR, Merkies ISJ, van Schaik IN; PATH study group.

Eur J Neurol. 2019 Aug 10. doi: 10.1111/ene.14056. [Epub ahead of print]

PMID:
31400231
3.

Reorganization of brain networks and its association with general cognitive performance over the adult lifespan.

Bagarinao E, Watanabe H, Maesawa S, Mori D, Hara K, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Taoka T, Koyama S, Tanabe HC, Katsuno M, Wakabayashi T, Kuzuya M, Ozaki N, Hoshiyama M, Isoda H, Naganawa S, Sobue G.

Sci Rep. 2019 Aug 6;9(1):11352. doi: 10.1038/s41598-019-47922-x.

4.

TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets.

Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M.

J Clin Invest. 2019 Jul 29;130. pii: 124481. doi: 10.1172/JCI124481. eCollection 2019 Jul 29.

5.

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study.

van Schaik IN, Mielke O, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Durn BL, Cornblath DR, Merkies ISJ; PATH study group.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 3;6(5):e590. doi: 10.1212/NXI.0000000000000590. eCollection 2019 Sep.

6.

Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).

Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Yasuda T, Mukai E, Date Y, Shiomi K, Nakazato M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):24-25. doi: 10.1080/13506129.2019.1582495. No abstract available.

PMID:
31343348
7.

Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):26. doi: 10.1080/13506129.2019.1582496. No abstract available.

PMID:
31343346
8.

Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.

Nakamura T, Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):6. doi: 10.1080/13506129.2019.1582018. No abstract available.

PMID:
31343341
9.

Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation.

Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Amyloid. 2019;26(sup1):13-14. doi: 10.1080/13506129.2019.1582023. No abstract available.

PMID:
31343285
10.

Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease.

Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, Koike H, Hashiguchi A, Takashima H, Sugiyama H, Kohno Y, Takiyama Y, Maeda K, Doi H, Koyano S, Takeuchi H, Kawamoto M, Kohara N, Ando T, Ieda T, Kita Y, Kokubun N, Tsuboi Y, Katoh K, Kino Y, Katsuno M, Iwasaki Y, Yoshida M, Tanaka F, Suzuki IK, Frith MC, Matsumoto N, Sobue G.

Nat Genet. 2019 Aug;51(8):1215-1221. doi: 10.1038/s41588-019-0459-y. Epub 2019 Jul 22.

PMID:
31332381
11.

A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease.

Ikenaka K, Tsukada Y, Giles AC, Arai T, Nakadera Y, Nakano S, Kawai K, Mochizuki H, Katsuno M, Sobue G, Mori I.

Sci Rep. 2019 Jul 12;9(1):10104. doi: 10.1038/s41598-019-46642-6.

12.

Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.

Ikeda S, Koike H, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):988-996. doi: 10.1136/jnnp-2019-320741. Epub 2019 Jun 21.

PMID:
31227562
13.

Tau isoform expression and phosphorylation in marmoset brains.

Sharma G, Huo A, Kimura T, Shiozawa S, Kobayashi R, Sahara N, Ishibashi M, Ishigaki S, Saito T, Ando K, Murayama S, Hasegawa M, Sobue G, Okano H, Hisanaga SI.

J Biol Chem. 2019 Jul 26;294(30):11433-11444. doi: 10.1074/jbc.RA119.008415. Epub 2019 Jun 5.

PMID:
31171723
14.

Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.

Riku Y, Duyckaerts C, Boluda S, Plu I, Le Ber I, Millecamps S, Salachas F; Brainbank NeuroCEB Neuropathology Network, Yoshida M, Ando T, Katsuno M, Sobue G, Seilhean D.

Acta Neuropathol. 2019 May 29. doi: 10.1007/s00401-019-02028-6. [Epub ahead of print]

PMID:
31144027
15.

Alterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System Atrophy.

Kawabata K, Hara K, Watanabe H, Bagarinao E, Ogura A, Masuda M, Yokoi T, Kato T, Ohdake R, Ito M, Katsuno M, Sobue G.

Cerebellum. 2019 Aug;18(4):770-780. doi: 10.1007/s12311-019-01031-7.

PMID:
31069705
16.

Clinical correlates of repetitive speech disorders in Parkinson's disease.

Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Sato M, Hattori M, Kawabata K, Hara K, Nakatsubo D, Maesawa S, Kajita Y, Katsuno M, Sobue G.

J Neurol Sci. 2019 Jun 15;401:67-71. doi: 10.1016/j.jns.2019.04.012. Epub 2019 Apr 11.

PMID:
31029883
17.

Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up.

Hijikata Y, Hashizume A, Yamada S, Ito D, Banno H, Suzuki K, Sobue G, Katsuno M.

Intern Med. 2019 Aug 1;58(15):2231-2234. doi: 10.2169/internalmedicine.1592-18. Epub 2019 Apr 17.

18.

Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells.

Sekine SI, Kaneko M, Tanaka M, Ninomiya Y, Kurita H, Inden M, Yamada M, Hayashi Y, Inuzuka T, Mitsui J, Ishiura H, Iwata A, Fujigasaki H, Tamaki H, Tamaki R, Kito S, Taguchi Y, Tanaka K, Atsuta N, Sobue G, Kondo T, Inoue H, Tsuji S, Hozumi I.

Sci Rep. 2019 Apr 5;9(1):5698. doi: 10.1038/s41598-019-42115-y.

19.

DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5.

Kondo N, Tohnai G, Sahashi K, Iida M, Kataoka M, Nakatsuji H, Tsutsumi Y, Hashizume A, Adachi H, Koike H, Shinjo K, Kondo Y, Sobue G, Katsuno M.

EMBO Mol Med. 2019 May;11(5). pii: e8547. doi: 10.15252/emmm.201708547.

20.

Editorial: Brain Protein Aging and Dementia Control.

Sobue G.

Front Neurosci. 2019 Mar 12;13:29. doi: 10.3389/fnins.2019.00029. eCollection 2019. No abstract available.

21.

Non-convulsive status epilepticus associated with neuronal intranuclear inclusion disease: A case report and literature review.

Shindo K, Tsuchiya M, Hata T, Ichinose Y, Koh K, Sone J, Nagasaka T, Sobue G, Takiyama Y.

Epilepsy Behav Case Rep. 2019 Jan 26;11:103-106. doi: 10.1016/j.ebcr.2019.01.007. eCollection 2019.

22.

Disease Affects Bdnf Expression in Synaptic and Extrasynaptic Regions of Skeletal Muscle of Three SBMA Mouse Models.

Halievski K, Nath SR, Katsuno M, Adachi H, Sobue G, Breedlove SM, Lieberman AP, Jordan CL.

Int J Mol Sci. 2019 Mar 15;20(6). pii: E1314. doi: 10.3390/ijms20061314.

23.

Increase of arginine dimethylation correlates with the progression and prognosis of ALS.

Ikenaka K, Atsuta N, Maeda Y, Hotta Y, Nakamura R, Kawai K, Yokoi D, Hirakawa A, Taniguchi A, Morita M, Mizoguchi K, Mochizuki H, Kimura K, Katsuno M, Sobue G.

Neurology. 2019 Apr 16;92(16):e1868-e1877. doi: 10.1212/WNL.0000000000007311. Epub 2019 Mar 13.

PMID:
30867270
24.

Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.

Hashizume A, Katsuno M, Suzuki K, Banno H, Takeuchi Y, Kawashima M, Suga N, Mano T, Araki A, Hijikata Y, Hirakawa A, Sobue G; JASMITT study group.

J Neurol. 2019 May;266(5):1211-1221. doi: 10.1007/s00415-019-09251-x. Epub 2019 Mar 7.

PMID:
30847645
25.

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.

Merkies ISJ, van Schaik IN, Léger JM, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Durn BL, Cornblath DR, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Tackenberg B, Mielke O; PRIMA Trial Investigators and the PATH Study Group.

J Peripher Nerv Syst. 2019 Mar;24(1):48-55. doi: 10.1111/jns.12302. Epub 2019 Feb 15.

26.

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.

Mielke O, Bril V, Cornblath DR, Lawo JP, van Geloven N, Hartung HP, Lewis RA, Merkies ISJ, Sobue G, Durn B, Shebl A, van Schaik IN; PATH study group.

J Peripher Nerv Syst. 2019 Mar;24(1):72-79. doi: 10.1111/jns.12303. Epub 2019 Mar 1.

27.

Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Neurology. 2018 Dec 4;91(23):1051-1060. doi: 10.1212/WNL.0000000000006625. Epub 2018 Nov 14. Review.

PMID:
30429275
28.

New teased-fibre definitions represent specific mechanisms of neuropathy.

Koike H, Katsuno M, Sobue G.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):124. doi: 10.1136/jnnp-2018-319493. Epub 2018 Nov 1. No abstract available.

PMID:
30385485
29.

Age-related impairment in Addenbrooke's cognitive examination revised scores in patients with amyotrophic lateral sclerosis.

Masuda M, Watanabe H, Tanaka Y, Ohdake R, Ogura A, Yokoi T, Imai K, Kawabata K, Riku Y, Hara K, Nakamura R, Atsuta N, Katsuno M, Sobue G.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):578-584. doi: 10.1080/21678421.2018.1510009. Epub 2018 Oct 31.

PMID:
30379106
30.

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.

Yokoi T, Watanabe H, Yamaguchi H, Bagarinao E, Masuda M, Imai K, Ogura A, Ohdake R, Kawabata K, Hara K, Riku Y, Ishigaki S, Katsuno M, Miyao S, Kato K, Naganawa S, Harada R, Okamura N, Yanai K, Yoshida M, Sobue G.

Front Aging Neurosci. 2018 Oct 5;10:304. doi: 10.3389/fnagi.2018.00304. eCollection 2018.

31.

The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Sakurai T, Shimohata T, Katsuno M, Sobue G.

J Neurol Sci. 2018 Nov 15;394:99-106. doi: 10.1016/j.jns.2018.09.011. Epub 2018 Sep 12.

PMID:
30243104
32.

Acute Unilateral Isolated Oculomotor Nerve Palsy in an Adult Patient with Influenza A.

Senda J, Araki K, Tachi Y, Watanabe H, Kagawashira Y, Ito M, Atsuta N, Katsuno M, Watanabe H, Sobue G.

Intern Med. 2019 Feb 1;58(3):433-436. doi: 10.2169/internalmedicine.0850-18. Epub 2018 Sep 12.

33.

Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent.

Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, Hadano S, Aoki M, Saya H, Sobue G, Okano H.

Nat Med. 2018 Oct;24(10):1579-1589. doi: 10.1038/s41591-018-0140-5. Epub 2018 Aug 20.

PMID:
30127392
34.

Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis.

Watanabe H, Riku Y, Hara K, Kawabata K, Nakamura T, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G.

J Mov Disord. 2018 Sep;11(3):107-120. doi: 10.14802/jmd.18020. Epub 2018 Aug 9.

35.

Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus.

Sobue G, Ishigaki S, Watanabe H.

Front Neurosci. 2018 Jul 12;12:473. doi: 10.3389/fnins.2018.00473. eCollection 2018. Review.

36.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.

Hughes R, Dalakas MC, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP; FORCIDP Trial Investigators.

Lancet Neurol. 2018 Aug;17(8):689-698. doi: 10.1016/S1474-4422(18)30202-3. Epub 2018 Jul 9. Erratum in: Lancet Neurol. 2018 Nov;17(11):933.

37.

Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.

Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G.

Intern Med. 2018 Dec 1;57(23):3365-3370. doi: 10.2169/internalmedicine.1113-18. Epub 2018 Jul 6.

38.

Corpus callosal involvement is correlated with cognitive impairment in multiple system atrophy.

Hara K, Watanabe H, Bagarinao E, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Tsuboi T, Ito M, Atsuta N, Niwa H, Taoka T, Maesawa S, Naganawa S, Katsuno M, Sobue G.

J Neurol. 2018 Sep;265(9):2079-2087. doi: 10.1007/s00415-018-8923-7. Epub 2018 Jul 5.

PMID:
29974207
39.

Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.

Xu Y, Halievski K, Katsuno M, Adachi H, Sobue G, Breedlove SM, Jordan CL.

Hum Mol Genet. 2018 Jul 15;27(14):2425-2442. doi: 10.1093/hmg/ddy142.

40.

[Sporadic adult-onset neuronal intranuclear inclusion disease with abnormal electroretinogram, nerve conduction studies and somatosensory evoked potential].

Hirose B, Hisahara S, Uesugi H, Sone J, Sobue G, Shimohama S.

Rinsho Shinkeigaku. 2018 Jun 27;58(6):407-410. doi: 10.5692/clinicalneurol.cn-001154. Epub 2018 Jun 1. Japanese.

PMID:
29863097
41.

Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.

Koike H, Yasuda T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Sobue G, Katsuno M.

Amyloid. 2018 Jun;25(2):141-142. doi: 10.1080/13506129.2018.1474734. Epub 2018 Jun 1. No abstract available.

PMID:
29855203
42.

Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model.

Mitsui S, Otomo A, Nozaki M, Ono S, Sato K, Shirakawa R, Adachi H, Aoki M, Sobue G, Shang HF, Hadano S.

Mol Brain. 2018 May 29;11(1):30. doi: 10.1186/s13041-018-0373-8.

43.

Importance of Functional Loss of FUS in FTLD/ALS.

Ishigaki S, Sobue G.

Front Mol Biosci. 2018 May 3;5:44. doi: 10.3389/fmolb.2018.00044. eCollection 2018. Review.

44.

Effects of Gradient Coil Noise and Gradient Coil Replacement on the Reproducibility of Resting State Networks.

Bagarinao E, Tsuzuki E, Yoshida Y, Ozawa Y, Kuzuya M, Otani T, Koyama S, Isoda H, Watanabe H, Maesawa S, Naganawa S, Sobue G.

Front Hum Neurosci. 2018 Apr 19;12:148. doi: 10.3389/fnhum.2018.00148. eCollection 2018.

45.

Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.

Kuwabara S, Misawa S, Mori M, Iwai Y, Ochi K, Suzuki H, Nodera H, Tamaoka A, Iijima M, Toda T, Yoshikawa H, Kanda T, Sakamoto K, Kusunoki S, Sobue G, Kaji R; Glovenin-I MMN Study Group.

J Peripher Nerv Syst. 2018 Jun;23(2):115-119. doi: 10.1111/jns.12268. Epub 2018 Apr 24.

46.

Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy.

Hijikata Y, Hashizume A, Yamada S, Inagaki T, Ito D, Hirakawa A, Suzuki K, Atsuta N, Tsuboi T, Hattori M, Hori A, Banno H, Sobue G, Katsuno M.

Neurology. 2018 Apr 24;90(17):e1501-e1509. doi: 10.1212/WNL.0000000000005360. Epub 2018 Mar 23.

PMID:
29572281
47.

Increased expression level of Hsp70 in the inner ears of mice by exposure to low frequency noise.

Ninomiya H, Ohgami N, Oshino R, Kato M, Ohgami K, Li X, Shen D, Iida M, Yajima I, Angelidis CE, Adachi H, Katsuno M, Sobue G, Kato M.

Hear Res. 2018 Jun;363:49-54. doi: 10.1016/j.heares.2018.02.006. Epub 2018 Feb 24.

PMID:
29519617
48.

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.

Hijikata Y, Katsuno M, Suzuki K, Hashizume A, Araki A, Yamada S, Inagaki T, Ito D, Hirakawa A, Kinoshita F, Gosho M, Sobue G.

JMIR Res Protoc. 2018 Mar 5;7(3):e69. doi: 10.2196/resprot.8655.

49.

Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years.

Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Atsuta N, Nakamura T, Hirayama M, Ogata H, Yamasaki R, Kira JI, Katsuno M, Sobue G.

Intern Med. 2018 Jul 15;57(14):2061-2066. doi: 10.2169/internalmedicine.0455-17. Epub 2018 Feb 28.

50.

[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].

Watanabe H, Hara K, Ito M, Katsuno M, Sobue G.

Brain Nerve. 2018 Feb;70(2):139-146. doi: 10.11477/mf.1416200966. Review. Japanese.

PMID:
29433115

Supplemental Content

Support Center